SCHEMBL24534795

SCHEMBL24534795

C/C=C1\N=C(c2ccc3ccccc3c2)OC1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.64
ERO1A Q96HE7 1/20 0.53
NOTUM Q6P988 4/20 0.50
SMN1; SMN2 Q16637 5/20 0.47
RAB9A P51151 7/20 0.45
NPC1 O15118 6/20 0.45
HPGD P15428 2/20 0.45
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ALDH1A1 P00352 3/20 0.44
GAA P10253 1/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
TNNI3 P19429 1/20 0.42
CRHBP P24387 1/20 0.42
TNNT2 P45379 1/20 0.42
TNNC1 P63316 1/20 0.42
CRHR2 Q13324 1/20 0.42
GSTP1 P09211 1/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24534666 1.00 ALOX5 (0.64) ALOX5ERO1ANOTUMSMN1; SMN2RAB9A
SCHEMBL9437566 0.82 ALOX5 (0.81) ALOX5ERO1ANOTUMALDH1A1GAA
SCHEMBL9437570 0.82 ALOX5 (0.81) ALOX5ERO1ANOTUMALDH1A1GAA
SCHEMBL22505232 0.81 SMN1; SMN2 (0.64) NOTUMSMN1; SMN2RAB9ANPC1HPGD
SCHEMBL12914553 0.80 SMN1; SMN2 (0.68) NOTUMSMN1; SMN2RAB9ANPC1HPGD
SCHEMBL21217197 0.80 SMN1; SMN2 (0.68) NOTUMSMN1; SMN2RAB9ANPC1HPGD
SCHEMBL22819051 0.78 ALOX5 (0.77) ALOX5ERO1ANOTUMSMN1; SMN2ALDH1A1
SCHEMBL24241399 0.78 NPC1 (0.69) NOTUMSMN1; SMN2RAB9ANPC1HPGD
SCHEMBL22500147 0.77 NOTUM (0.70) ALOX5ERO1ANOTUMHPGDHTT
SCHEMBL22500146 0.77 NOTUM (0.70) ALOX5ERO1ANOTUMHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220193041-A1 NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT Yonsei University, University - Industry Foundation (UIF) (KR) 2022-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220193041-A1 NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT EPX, CFTR, MPO ALOX5 105/4885ERO1A 1304/4885NOTUM 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.